MedTrace Logo

Pectoral Nerves Block to Relieve Post-sternotomy Pain After Cardiac Surgery

NCT04282239 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2021-12-29

No results posted yet for this study

Summary

The primary objective of this study is to determine if the addition of PECS2 block provides superior post-operative analgesia for cardiac surgery patients after midline sternotomy compared to only standard-of-care post-operative pain medication.

Conditions

  • Pain, Postoperative
  • Cardiac Surgery

Interventions

PROCEDURE

PECS2 block

Superficial peripheral nerve block placed at the interfascial plane between the pectoralis major and minor muscles and the plane between the pectoralis minor and serrates anterior muscles. Targeted nerves include the lateral and medial pectoral nerves in addition to the long thoracic nerve, thoracodorsal, and thoracic intercostal nerves from T2 to T6.

DRUG

Ropivacaine 0.5% Injectable Solution

15 mL on each side of anterior chest for a total of 30mL

DRUG

Lidocaine Epinephrine

10 mL on each side of anterior chest for a total of 20mL

DRUG

Dexmedetomidine 0.004 MG/ML

10 mL

Sponsors & Collaborators

Principal Investigators

  • Sunil Abrol, MD · NYU Langone Health

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-01
Primary Completion
2021-12-31
Completion
2022-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04282239 on ClinicalTrials.gov